Aarti Pharmalabs Ltd
Fri 22/05/2026,15:46:10 | NSE : AARTIPHARM
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 703.50
Previous Close
₹ 703.50
Volume
128328
Mkt Cap ( Rs. Cr)
₹6464.80
High
₹ 727.25
Low
₹ 702.65
52 Week High
₹ 971.00
52 Week Low
₹ 585.00
Book Value Per Share
₹ 230.45
Dividend Yield
0.00
Face Value
₹ 5.00
What’s Your Call?
Collective community sentiment on Aarti Pharmalabs Ltd
Your Vote -
Buy
92.31%
Hold
0.00%
Sell
7.69%
92.31%
13 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
713.10
330
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
330
Option Chain
Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Aarti Pharmalabs - Update on board meeting
-
Aarti Pharmalabs - Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year
-
Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Aarti Pharmalabs - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Aarti Pharmalabs - Copy of Newspaper Publication
-
Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Aarti Pharmalabs - Updates
-
Aarti Pharmalabs - Intimation Regarding Second 100-Day Campaign - 'Saksham Niveshak'
-
Aarti Pharmalabs - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulati
-
Aarti Pharmalabs - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulati
-
Aarti Pharmalabs - Updates
-
Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Aarti Pharmalabs - Trading Window
-
Aarti Pharmalabs - Updates
Key fundamentals
Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | |
|---|---|---|---|---|---|
| Assets | 2238.7261 | 1872.2571 | 1645.2909 | 1608.9004 | |
| Liabilities | 2238.7261 | 1872.2571 | 1645.2909 | 1608.9004 | |
| Equity | 45.3173 | 45.313 | 45.313 | 45.563 | |
| Gross Profit | 426.5433 | 346.1585 | 308.3352 | 179.7858 | |
| Net Profit | 257.3488 | 200.6454 | 171.7268 | 106.7261 | |
| Cash From Operating Activities | 340.0057 | 183.6944 | 228.6894 | -64.8426 | |
| NPM(%) | 14.52 | 13.35 | 11.36 | 11.34 | |
| Revenue | 1771.3518 | 1502.1319 | 1511.2478 | 941.021 | |
| Expenses | 1344.8085 | 1155.9734 | 1202.9126 | 761.2352 | |
| ROE(%) | 12.31 | 9.6 | 8.21 | 5.1 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 16 Feb 2026 | 1.5 | 30 | 0 | 794.75 |
| 15 Sep 2025 | 2.5 | 50 | 0 | 799.45 |
| 14 Feb 2025 | 2.5 | 50 | 0 | 636.3 |
| 31 Jul 2024 | 1 | 20 | 0 | 520.05 |
| 2 | 40 | 0 | 557.85 |
Peers
Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Nitta Gelatin India Ltd | 1420.85 | 5.34 | 13.27 | 648.71 | 1071.07 | 0.00 |
| Sharda Cropchem Ltd | 893.10 | -1.47 | 11.83 | 6446.25 | 754.66 | 1.68 |
| Amines and Plasticizers Ltd | 190.60 | -2.77 | 30.84 | 3931.18 | 372.61 | 0.26 |
| Indogulf Cropsciences Ltd | 61.62 | -0.76 | 10.20 | 3485.83 | 49.78 | 0.00 |
Company Info
Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company 2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd. 2025 -Aarti Pharmalabs Ltd. Credit Rating Upgraded to CRISIL AA-/Stable, Reflecting Strong Financial Health and Business Prospects. -Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability. -Aarti Pharmalabs Ltd. Achieves Key Sustainability Milestone with Approval of GHG Emission Reduction Targets by Science Based Target initiative (SBTi).
Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company 2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd. 2025 -Aarti Pharmalabs Ltd. Credit Rating Upgraded to CRISIL AA-/Stable, Reflecting Strong Financial Health and Business Prospects. -Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability. -Aarti Pharmalabs Ltd. Achieves Key Sustainability Milestone with Approval of GHG Emission Reduction Targets by Science Based Target initiative (SBTi).
Read More
Parent Organisation
Aarti Pharmalabs Ltd.
Founded
22/11/2019
Managing Director
Mr.Narendra J Salvi
NSE Symbol
AARTIPHARMEQ
FAQ
The current price of Aarti Pharmalabs Ltd is ₹ 713.10.
The 52-week high for Aarti Pharmalabs Ltd is ₹ 727.25 and the 52-week low is ₹ 702.65.
The market capitalization of Aarti Pharmalabs Ltd is currently ₹ 6464.80. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Aarti Pharmalabs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Aarti Pharmalabs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarti Pharmalabs Ltd shares.
The CEO of Aarti Pharmalabs Ltd is Mr.Narendra J Salvi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
